SCHEMBL21251733

SCHEMBL21251733

CCOC1(C)CN(c2nc(-c3c(F)c(OC)cc(OC)c3F)cc3cnc(SC)nc23)C1

nearest known ligand 0.38

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
▸ TTK P33981 4/20 0.38
▸ FGFR4 P22455 1/20 0.31
▸ MEN1 O00255 1/20 0.30
▸ KMT2A Q03164 1/20 0.30
▸ CCNA2 P20248 1/20 0.30
▸ CDK2 P24941 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20331754 0.91 FGFR4 (0.33) TTKFGFR4
SCHEMBL30045025 0.91 FGFR4 (0.33) TTKFGFR4
SCHEMBL30442688 0.87 TTK (0.34) TTKFGFR4
SCHEMBL30045165 0.85 TTK (0.33) TTKFGFR4
SCHEMBL20331960 0.85 TTK (0.33) TTKFGFR4
SCHEMBL20331784 0.83 TTK (0.36) TTKFGFR4
SCHEMBL30046092 0.83 TTK (0.36) TTKFGFR4
SCHEMBL21240493 0.83 TTK (0.38) TTKFGFR4
SCHEMBL29578139 0.83 TTK (0.38) TTKFGFR4
SCHEMBL30442682 0.83 NOS1 (0.36) TTKFGFR4MEN1KMT2ACCNA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3524603-A1 FGFR4 INHIBITOR, PREPARATION METHOD THEREFOR AND PHARMACEUTICAL USE THEREOF Abbisko Therapeutics Co., Ltd. (CN) 2019-08-14 — — EP disclosed
Send feedback